BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shi TD, Wu YZ, Jia ZC, Zou LY, Zhou W. Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD8+ CTL-mediated cytotoxicity in HLA-A2+ human PBMCs. World J Gastroenterol 2004; 10(13): 1902-1906 [PMID: 15222033 DOI: 10.3748/wjg.v10.i13.1902]
URL: https://www.wjgnet.com/2218-6190/full/v10/i13/1902.htm
Number Citing Articles
1
Wei Cao, Zhifeng Qiu, Ting Zhu, Yanling Li, Yang Han, Taisheng Li. CD8+ T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infectionJournal of Clinical Virology 2014; 61(1): 40 doi: 10.1016/j.jcv.2014.06.022
2
Jianqiang Li, Mengru Bao, Jun Ge, Sulin Ren, Tong Zhou, Fengchun Qi, Xiuying Pu, Jia Dou. Research progress of therapeutic vaccines for treating chronic hepatitis BHuman Vaccines & Immunotherapeutics 2017; 13(5): 986 doi: 10.1080/21645515.2016.1276125
3
Yan Lin, Yu Dong, Yanfeng Gao, Ranran Shi, Yubing Li, Xiuman Zhou, Wenwen Liu, Guodong Li, Yuanming Qi, Yahong Wu, Youmin Kang. Identification of CTL Epitopes on Efflux Pumps of the ATP-Binding Cassette and the Major Facilitator Superfamily of Mycobacterium tuberculosisJournal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/8899674
4
Yaakov Maman, Antoine Blancher, Jennifer Benichou, Adi Yablonka, Sol Efroni, Yoram Louzoun. Immune-Induced Evolutionary Selection Focused on a Single Reading Frame in Overlapping Hepatitis B Virus ProteinsJournal of Virology 2011; 85(9): 4558 doi: 10.1128/JVI.02142-10
5
Murali Ganesan, Vjaceslav M. Krutik, Edward Makarov, Saumi Mathews, Kusum K. Kharbanda, Larisa Y. Poluektova, Carol A Casey, Natalia A. Osna. Acetaldehyde suppresses the display of HBV-MHC class I complexes on HBV-expressing hepatocytesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2019; 317(2): G127 doi: 10.1152/ajpgi.00064.2019
6
Azam Askari, Gholam Hossein Hassanshahi, Seyed Razi Ghalebi, Abdollah Jafarzadeh, Maryam Mohit, Masomeh Hajghani, Mohammad Kazemi Arababadi. Intensity of HLA-A2 Expression Significantly Decreased in Occult Hepatitis B InfectionJundishapur Journal of Microbiology 2014; 7(6) doi: 10.5812/jjm.10298
7
J. Rajčáni, S. Szathmary. Peptide Vaccines: New Trends for Avoiding the Autoimmune ResponseThe Open Infectious Diseases Journal 2018; 10(1): 47 doi: 10.2174/1874279301810010047
8
Heng-Gui Liu, Wei-wei Chen, Zhen-Ping Fan, Hui-ying Yang, Ming Shi, Zheng Zhang, Shen-Shun Luan, Hui Zhang, Peng Lu, Po Tien, Fu-Sheng Wang. The high prevalence of the I27 mutant HBcAg18–27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitopeClinical Immunology 2007; 125(3): 337 doi: 10.1016/j.clim.2007.06.010
9
Artur A. M. L. Brandt, Rodrigo N. Rodrigues-da-Silva, Josué C. Lima-Junior, Carlos R. Alves, Franklin de Souza-Silva, Sebastien Fiorucci. Combining Well-Tempered Metadynamics Simulation and SPR Assays to Characterize the Binding Mechanism of the Universal T-Lymphocyte Tetanus Toxin Epitope TT830-843BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/5568980
10
Suna Wang, Qunying Han, Ni Zhang, Jinghong Chen, Zhengwen Liu, Guoyu Zhang, Zhu Li. HBcAg18–27 epitope fused to HIV-Tat49–57 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic miceImmunology Letters 2010; 127(2): 143 doi: 10.1016/j.imlet.2009.10.011
11
Sandra Phillips, Shilpa Chokshi, Antonio Riva, Alexander Evans, Roger Williams, Nikolai V. Naoumov. CD8+T Cell Control of Hepatitis B Virus Replication: Direct Comparison between Cytolytic and Noncytolytic FunctionsThe Journal of Immunology 2010; 184(1): 287 doi: 10.4049/jimmunol.0902761
12
Nanna-Sophie Brinck-Jensen, Thomas Vorup-Jensen, Peter Derek Christian Leutscher, Christian Erikstrup, Eskild Petersen. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBVBMC Immunology 2015; 16(1) doi: 10.1186/s12865-015-0127-7
13
Dezhi Li, Zelong Dou, Yahong Wu, Yuanming Qi, Junhui Chen, Yanfeng Gao. Identification of Novel Cytotoxic T Lymphocyte Epitopes of Drug- Resistance Related Protein InhA from Mycobacterium tuberculosisProtein & Peptide Letters 2020; 27(11): 1141 doi: 10.2174/0929866527666200505215346
14
Xing-bin Hu, Qiao-hong Yue, Hai-feng Ouyang, Yao-zhen Chen, Xue-qing Xu, Wen Yin, San-hua Wei, Xian-qing Zhang, Shi-jie Mu. Immune response to fused core protein of hepatitis C virus and truncated tetanus toxin peptides in miceArchives of Virology 2010; 155(7): 1097 doi: 10.1007/s00705-010-0692-2
15
Murali Ganesan, Weimin Wang, Saumi Mathews, Edward Makarov, Moses New‐Aaron, Raghubendra Singh Dagur, Antje Malo, Ulrike Protzer, Kusum K. Kharbanda, Carol A. Casey, Larisa Y. Poluektova, Natalia A. Osna. Ethanol attenuates presentation of cytotoxic T‐lymphocyte epitopes on hepatocytes of HBV‐infected humanized miceAlcoholism: Clinical and Experimental Research 2022; 46(1): 40 doi: 10.1111/acer.14740
16
Wonderful Tatenda Choga, Motswedi Anderson, Edward Zumbika, Bonolo B. Phinius, Tshepiso Mbangiwa, Lynnette N. Bhebhe, Kabo Baruti, Peter Opiyo Kimathi, Kaelo K. Seatla, Rosemary M. Musonda, Trevor Graham Bell, Sikhulile Moyo, Jason T. Blackard, Simani Gaseitsiwe. In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in BotswanaViruses 2020; 12(7): 731 doi: 10.3390/v12070731
17
Yutaka Tsutsumi, Hiroe Kanamori, Akio Mori, Junji Tanaka, Masahiro Asaka, Masahiro Imamura, Nobuo Masauzi. Reactivation of hepatitis B virus with rituximabExpert Opinion on Drug Safety 2005; 4(3): 599 doi: 10.1517/14740338.4.3.599
18
Suna Wang, Qunying Han, Guoyu Zhang, Ni Zhang, Zhu Li, Jinghong Chen, Yi Lv, Na Li, Fanfan Xing, Ningqiang Tian, Qianqian Zhu, Zhengwen Liu. CpG oligodeoxynucleotide-adjuvanted fusion peptide derived from HBcAg epitope and HIV-Tat may elicit favorable immune response in PBMCs from patients with chronic HBV infection in the immunotolerant phaseInternational Immunopharmacology 2011; 11(4): 406 doi: 10.1016/j.intimp.2010.12.005
19
Fu-Qiang Yang, Gui-Rong Rao, Gui-Qiang Wang, Yue-Qi Li, Yao Xie, Zhan-Qing Zhang, Cun-Liang Deng, Qing Mao, Jun Li, Wei Zhao, Mao-Rong Wang, Tao Han, Shi-Jun Chen, Chen Pan, De-Ming Tan, Jia Shang, Ming-Xiang Zhang, Yue-Xin Zhang, Ji-Ming Yang, Guang-Ming Chen. Phase IIb trial of <i>in vivo</i> electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapyWorld Journal of Gastroenterology 2017; 23(2): 306-317 doi: 10.3748/wjg.v23.i2.306